RTXM83

RTXM83 · mAbxience Research S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RTXM83, covering 2019-09-26 to 2019-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma [Phase 3]

See pricing